APOB rs121964858: Understanding Familial Ligand-Defective ApoB
The rs121964858 variant is a specific genetic change located within the APOB gene. It is associated with familial ligand-defective apolipoprotein B-100, a condition that can influence how the body processes cholesterol.
What each genotype means
Typical cholesterol processing
This genotype represents the most common form of the APOB gene in the general population. It is not associated with the specific ligand-defective cholesterol processing linked to this variant. You should continue to follow standard heart health guidelines and discuss your cholesterol levels with your healthcare provider.
Carried by the vast majority of individuals across all global populations.
Increased cholesterol risk
This genotype is associated with Familial Ligand-Defective ApoB, a condition that can impair the body's ability to clear LDL cholesterol from the blood. Individuals with this profile may have higher baseline cholesterol levels and should discuss appropriate screening and management strategies with their clinician.
Carried by approximately 0.1% of people of European ancestry, with lower frequencies observed in other populations.
Elevated cholesterol risk
This genotype indicates the presence of two copies of the variant associated with Familial Ligand-Defective ApoB. Research suggests this may lead to more pronounced challenges in cholesterol metabolism compared to carrying a single copy. It is important to consult with a cardiologist or lipid specialist to monitor your cardiovascular health.
This genotype is extremely rare in the general population, occurring in significantly less than 0.01% of individuals.
What is the rs121964858 Variant?
The rs121964858 variant is a single nucleotide polymorphism (SNP) found within the APOB gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is categorized as a trait-associated marker. It is located in a region of the gene that encodes for the apolipoprotein B-100 protein, which is a critical component of low-density lipoprotein (LDL) particles. When a variation occurs in this region, it can potentially alter the structure or function of the resulting protein, which may impact how effectively the body clears cholesterol from the bloodstream. Understanding the location and nature of this variant helps researchers study the underlying mechanisms of lipid metabolism and how genetic differences contribute to variations in cholesterol levels among individuals.
The Role of the APOB Gene
The APOB gene provides instructions for making apolipoprotein B-100, a protein that acts as the primary structural component of LDL particles, often referred to as 'bad' cholesterol. These particles are responsible for transporting cholesterol through the bloodstream to cells throughout the body. The LDL receptor on the surface of cells recognizes and binds to apolipoprotein B-100, allowing the cell to take up the LDL particle and remove it from circulation. When the APOB gene contains certain variants, the resulting protein may have a reduced ability to bind to the LDL receptor. This impairment can lead to a buildup of LDL cholesterol in the blood, a condition known as hypercholesterolemia. Because the APOB gene is central to lipid transport, variations within it are frequently studied in the context of cardiovascular health and metabolic disorders.
Research and Evidence
Research into rs121964858 has identified it as a factor in familial ligand-defective apolipoprotein B-100. The evidence strength for this association is currently considered moderate. Studies suggest that this variant can lead to a reduced affinity between the apolipoprotein B-100 protein and the LDL receptor, which hinders the efficient clearance of LDL particles. While this mechanism is well-documented for several APOB variants, the clinical impact of specific variants can vary between individuals. It is important to note that while genetic factors play a significant role in cholesterol levels, they are not the only influence. Lifestyle factors, diet, and other genetic markers also contribute to an individual's overall lipid profile. Current research continues to refine our understanding of how this specific variant interacts with other biological systems to influence health outcomes.
Population Frequency
The rs121964858 variant is relatively rare in the general population. Current data indicates a frequency of approximately 0.1% in European populations. Because this variant is not common, it is often studied in the context of specific families or clinical cohorts where individuals present with unexplained high cholesterol. The frequency can vary significantly across different ancestral groups, and more research is needed to fully map its distribution globally. Understanding the prevalence of such variants is essential for genetic counselors and clinicians who evaluate patients with familial patterns of lipid disorders. If you have concerns about your cholesterol levels or family history, it is recommended to consult with a healthcare provider who can interpret genetic information in the context of your overall health.
Managing Genetic Information
Knowing your status for the rs121964858 variant provides information about a potential genetic predisposition, but it does not constitute a medical diagnosis. Genetic variants are only one piece of a complex puzzle that includes your environment, diet, and other genetic factors. If you have received results indicating you carry this variant, you should discuss the findings with a qualified clinician or a genetic counselor. They can help you understand what this means for your health and whether any specific screenings or lifestyle adjustments are appropriate. You cannot use this information to self-diagnose or determine medication needs. Always rely on professional medical advice for managing cholesterol levels, and never make changes to prescribed treatments without consulting your doctor or pharmacist.
How common is this variant?
The rs121964858 variant is found at a frequency of approximately 0.1% in European populations.
Frequently asked questions
What is familial ligand-defective apolipoprotein B-100?
It is a genetic condition where a mutation in the APOB gene makes it difficult for LDL particles to bind to their receptors. This can lead to higher levels of LDL cholesterol in the blood.
Does having this variant mean I have high cholesterol?
Not necessarily. While this variant is associated with a risk of higher cholesterol, many factors influence your levels, including diet, exercise, and other genes. A blood test is the only way to determine your actual cholesterol levels.
Should I get tested for this variant?
Genetic testing is usually recommended by a doctor if there is a strong family history of high cholesterol or early heart disease. You should discuss the necessity of testing with your healthcare provider.
Can I change my genes if I have this variant?
No, you cannot change your genetic code. However, knowing your genetic risks can help you and your doctor create a personalized plan to manage your cholesterol through lifestyle changes or medication.
Sources & further reading
Educational information only, last refreshed 10/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121964858?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29